Stock Watch: Where Novo And Lilly Lead, Others Follow

AstraZeneca Resurrects Its Metabolic Franchise

 
• By Andy Smith
  
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Business